Summary
This article is a review of the principal drug-induced psychiatric symptoms that are likely to be encountered in daily clinical practice as a result of drug abuse, overdoses or side effects of drugs prescribed for treatment. Many categories of medication have the potential to produce psychiatric symptoms, but antitubercular drugs, hypotensive agents and steroids have the highest incidence in clinical practice. Additionally, the problems of alcohol are all too frequently overlooked. The variety and frequency of secondary psychiatric symptoms which may be drug-related emphasise the importance of a careful consideration of all drugs taken by a patient with psychiatric complaints, to determine causal association with symptoms.
Similar content being viewed by others
References
Baker, J.P. and Farley, J.D.: Toxic psychosis following atropine eye drops. British Medical Journal 2: 1390 (1958).
Batchelor, I.R.C.: Alcoholism and attempted suicide. Journal of Mental Science 100: 451 (1954).
Bauer, G.E.; Croll, F.J.T.; Goldrick, R.B.; Jeremy, D.; Raftos, J.; Whyte, H.M. and Young, A.A.: Guanethidine in the treatment of hypertension. British Medical Journal 2: 410 (1961).
Baumblatt, M.J. and Winston, F.: Pyridoxine and the pill. Lancet 1: 832 (1970).
Bell, D.S.: Comparison of amphetamine psychosis and schizophrenia. British Journal of Psychiatry 111: 701 (1965).
Benedetti, G.: Alkoholhalluzinosen. (Thieme, Stuttgart 1952).
Biemond, A.: Wernicke’s encephalopathy and Korsakov’s syndrome. Psychiatric Clinical (Basel) 2: 146 (1969).
Blane, H.T.; Overton, W.F. and Chafetz, M.E.: Social factors in the diagnosis of alcoholism. Quarterly Journal of Studies in Alcohol 26: 640 (1963).
Brewer, C. and Perrett, L.: Brain damage due to alcohol consumption — an air-encephalographic, psychometric and electroen-cephalographic study. British Journal of Addiction 66: 170 (1971).
British National Formulary. British Medical Association and the Pharmaceutical Society of Great Britain, pp.132–133 (1981).
British Tuberculosis Association: A comparison of prothionamide and ethionamide. Tubercle (London) 49: 25 (1968).
Brogden, R.N.; Speight, T.M. and Avery, G.S.: Levodopa: a review of its pharmacological properties and therapeutic uses with particular reference to Parkinsonism. Drugs 2: 262 (1971).
Bunney, W.E. and Davis, J.M.: Norepinephrine in depressive reactions. Archives of General Psychiatry 13: 483 (1965).
Campbell, A.C.P. and Russell, W.R.: Wernicke’s encephalopathy: their clinical features and their probable relationship to Vitamin B deficiency. Quarterly Journal of Medicine 10: 41 (1941).
Chaturachinda, K. and McGregor, E.M.: Wernicke’s encephalopathy and pregnancy. Journal of Obstetrics and Gynaecology of the British Commonwealth, 75: 969 (1968).
Connell, P.H.: Amphetamine Psychosis (Maudsley Monograph No. 5). Institute of Psychiatry, London. Chapman (1958).
Crowell, E.B. and Ketchum, J.S.: The treatment of scopolamine induced delirium with physostigmine. Clinical Pharmacology and Therapeutics 8: 409 (1967).
Curran, F.J.: The symptoms and treatment of barbiturate intoxication and psychosis. American Journal of Psychiatry 95: 73 (1938).
Curran, F.J.: Current views on neuropsychiatric effects of barbiturates and bromides. Journal of Nervous and Mental Disease 100: 142 (1944).
Dameshek, W. and Feinsilver, O.: The use of acetyl-beta-methyl choline chloride (mecholyl) as a diagnostic test for poisoning by atropine drugs. Journal of the American Medical Association 109: 561 (1937).
Dollery, C.T.; Enslie-Smith, D. and Milne, M.D.: Clinical and pharmacological studies with guanethidine in the treatment of hypertension. Lancet 2: 381 (1960).
Drenick, E.J.; Joven, C.B. and Swendseid, M.E.: Occurrence of acute Wernicke’s encephalopathy during prolonged starvation for the treatment of obesity. New England Journal of Medicine 274: 937 (1966).
Duvoisin, R.C. and Katz, R.: Reversal of central anticholinergic syndrome in man by physostigmine. Journal of the American Medical Association 206: 1963 (1968).
Eastwood, M.R.; Mindham, R.H.S. and Tennent, T.G.: The physical status of psychiatric emergencies. British Journal of Psychiatry 116: 545 (1970).
Enoch, M.D.; Trethowan, W.H. and Barker, J.C.: Some Uncommon Psychiatric Syndromes (John Wright, Bristol 1967).
Evanson, J.M. and Sears, H.T.N.: Comparison of bretylium tosylate with guanethidine in the treatment of severe hypertension. Lancet 2: 381 (1960).
Forrer, G.R. and Miller, J.J.: Atropine coma: a somatic therapy in psychiatry. American Journal of Psychiatry 115: 455 (1958).
Frantzen, E.: Wernicke’s encephalopathy. Three cases in connection with severe malnutrition. Acta Neurologica Scandinavica 42: 426 (1966).
Eraser, H.F.; Wikler, A.; Essig, C.F. and Isbell, H.: Degree of physical dependence induced by secobarbital or pentobarbital. Journal of the American Medical Association 166: 126 (1958).
Freedman, D.X.: On the use and abuse of LSD. Archives of General Psychiatry 18: 330 (1968).
Goodwin, D.W.; Crane, J.B. and Guze, S.B.: Alcoholic blackouts: A review and clinical study of 100 alcoholics. American Journal of Psychiatry 126: 191 (1969a).
Goodwin, D.W.; Crane, J.B. and Guze, S.B.: Phenomenological aspects of the alcoholic blackout. British Journal of Psychiatry 115: 1033 (1969b).
Glatt, M.: Alcoholism and attempted suicide. British Medical Journal 2: 991 (1954).
Glatt, M.: Alcoholism and epilepsy. British Medical Journal 2: 737 (1955).
Glick, I.D.: Mood and behavioural changes associated with the use of oral contraceptive agents. A review of the literature. Psychopharmacologia 10: 363 (1967).
Granville-Grossman, K.: Recent advances in Clinical Psychiatry. (J. & A. Churchill, London 1971).
Green, J.R.: The incidence of alcoholism in patients admitted to medical wards of a public hospital. Medical Journal of Australia 1: 465 (1965).
Greenberg, R. and Pearlman, C.: Delirium tremens and dreaming. American Journal of Psychiatry 124: 133 (1967).
Griffin, J.P. and D’Arcy, P.F.: in Adverse Drug Interactions, p.XIV (Billing and Sons Ltd, Guildford, London and Worcester, 1979).
Gross, M.M. and Goodenough, D.R.: Sleep disturbances in the acute alcoholic psychoses. Psychiatric Reports of the American Psychiatric Association 24: 132 (1968).
Greer, H.D.; Ward, H.P. and Corbin, K.B.: Chronic salicylate intoxication in adults. Journal of the American Medical Association 193: 555 (1965).
Guttman, E.: The effects of benzedrine on depressive states. Journal of Mental Science 82: 618 (1936).
Guttman, E. and Sargent, W.: Observations on benzedrine. British Medical Journal 1: 1013 (1937).
Harington, M. and Kincaid-Smith, P.: Psychosis and tremor due to mecamylamine. Lancet 1: 499 (1958).
Hoefnagel, D.: Toxic effects of atropine and homatropine eye drops in children. New England Journal of Medicine 264: 168 (1961).
Hore, B.D.: Alcohol Dependence (Butterworths, London 1976).
Isbell, H.; Altschul, S.; Kornetsky, C.H.; Eisenman, A.J.; Flanary, H.G. and Fraser, H.F.: Chronic barbiturate intoxication. Archives of Neurology and Psychiatry 64: 1 (1950).
Isbell, H.; Belleville, R.E.; Fraser, H.F.; Wikler, A. and Logan, C.R.: Studies on lysergic acid. Archives of Neurology and Psychiatry 76: 468 (1956).
Johanson, E.: Acute hallucinosis, paranoic reactions and schizophreniform psychosis in alcoholic patients. Acta Soc. Med. (Uppsala) 66: 105 (1961).
Johnson, D.A.W.: Evaluation of routine physical examination in psychiatric patients. Practitioner 200: 686 (1968).
Johnson, D.A.W.: Physical illness in psychiatric patients. British Journal of Psychiatry 115: 122 (1969).
Johnson, D.A.W.: The psychiatric side-effects of drugs. Practitioner 209: 320 (1972).
Johnson, D.A.W.: An analysis of out-patient services. British Journal of Psychiatry 122: 301 (1973).
Johnston, A.W.; Prichard, B.N.C. and Rosenheim, M.C.: The use of bethanidine in the treatment of hypertension. Lancet 2: 659 (1964).
Joyce, C.R.D.: Cannabis; in Silverstone and Barraclough (Eds) Contemporary Psychiatry (Headley Bros. Ashford, Kent 1970).
Kane, F.J.: Psychiatric reactions to oral contraceptives. American Journal of Obstetrics and Gynaecology 102: 363 (1967).
Keeler, M.H.; Reifler, C.B. and Liptzin, M.B.: Spontaneous recurrence of marihuana effect. American Journal of Psychiatry 125: 140 (1968).
Kessel, N. and Grossman, G.: Suicide in alcoholics. British Medical Journal 2: 1671 (1961).
Lauler, D.P. and Thorn, G.W.: Diseases of the adrenal cortex; In Harrison et al. (Eds) Principles of Internal Medicine, pp.449.484 (New York 1966).
Leading Article: Oral contraceptives and depression. British Medical Journal 2: 380 (1969).
Lees, A.W.: Ethionamide 1000mg and isoniazid 400mg in previously untreated cases of pulmonary tuberculosis. British Journal of Diseases of the Chest 59: 228 (1965a).
Lees, A.W.: Ethionamide 750mg plus isoniazid 450mg in previously untreated cases of pulmonary tuberculosis. American Review of Respiratory Diseases 92: 966 (1965b).
Leishman, A.W.D.; Mathews, H.L. and Smith, A.J.: Guanethidine. Hypotensive drug with a prolonged action. Lancet 2: 659 (1959).
Lemieux, G.; Davignon, A. and Genost, J.: Depressive states during rauwolfia therapy for arterial hypertension. A report of 30 cases. Canadian Medical Association Journal 74: 522 (1956).
Lewis, W.C.; Calden, G.; Thurston, J.R. and Gibson, W.E.: Psychiatric and neurological reactions to cycloserine in the treatment of tuberculosis. Diseases of the Chest 32: 172 (1957).
Lewis, S.A.; Oswald, I. and Dunleavy, D.L.F.: Chronic fenfluramine administration: some cerebral effects. British Medical Journal 3: 67 (1971).
Lingjaerde, O.: Tetrabenazine in the treatment of psychoses. Acta Psychiatrica Scandinavica Suppl. (1970).
Lishman, W.A.: Organic Psychiatry: Psychological Consequences of Cerebral Disorder. (Blackwell Scientific Publications, Oxford 1978).
Lowther, C.P. and Turner, R.W.D.: Guanethidine in the treatment of hypertension. British Medical Journal 2: 776 (1963).
Malamud, N. and Skillicorn, S.A.: Relationship between the Wernicke and the Korsakoff syndrome. Archives of Neurology and Psychiatry 76: 585 (1956).
Mark, H.H.: Psychotogenic properties of cyclopentolate. Journal of the American Medical Association 186: 430 (1963).
Markovitz, M.: Acute intermittent porphyria: a report of five cases and a review of the literature. Annals of Internal Medicine 41: 1170 (1954).
Marshall, M.E.S.: Incidence of physical disorders among psychiatric in-patients. British Medical Journal 2: 468 (1949).
Martindale Extra Pharmacopoeia (Ed. R.G. Todd) pp.104, 1162–1165 (Pharmaceutical Press, London 1967).
Mattingley, D.: Disorders of the adrenal cortex and pituitary gland; in Baron, Compston and Dawson (Eds) Recent Advances in Medicine, pp. 125–169 (Churchill-Livingstone, Edinburgh 1968).
May, P.R.A. and Ebaugh, F.G.: Pathological intoxication, alcoholic hallucinosis and other reactions to alcohol: A clinical study. Quarterly Journal of Studies on Alcohol 14: 200 (1953).
Mendellson, J.H.; Ogata, M. and Mello, N.K.: Effects of alcohol ingestion and withdrawal on magnesium states of alcoholics — clinical and experimental findings. Annals of New York Academy of Science 162: 934 (1969).
Meyer, L. and Herxheimer, A.: in Side-Effects of Drugs, pp. 1–97, 224 (Excerpta Medica, Amsterdam 1972).
Meyler, L. and Herxheimer, A.: Side effects of drugs: A survey of unwanted effects of drugs reported 1965–1967, Vol. 6 (Excerpta Medica, Amsterdam 1968).
Michael, R.P. and Gibbons, J.L.: Inter-relationships between the endocrine system and neuropsychiatry. International Review of Neurobiology 5: 243 (1963).
Morozov, G.V.; Kachaev, A.K. and Lukacher, C.I.: The pathogenesis of pathological inebriation. Zhurnal Neuropatologii i Psikhiatrii Korsakov 73: 1196 (1973).
Murray, R.M.; Greene, J.G. and Adams, J.H.: Analgesic abuse and dementia. Lancet 2: 242 (1971).
Nahas, G.G.: Toxicology and pharmacology of cannabis sativa with special reference to 9-THC. Bulletin on Narcotics 24: 11 (1972).
Nielsen, J.B.; Drivsholn, A.; Fischer, F. and Brochner-Mortensen, K.: Long term treatment with corticosteroids in rheumatic arthritis. Acta Medica Scandinavica 173: 177 (1963).
Nolan, J.P.: Alcohol as a factor in the illness of university service patients. American Journal of Medical Science 249: 135 (1965).
Olsen, P.V. and Torning, K.: Isoniazid and loss of memory. Scandinavian Journal of Respiratory Disease 49: 1 (1968).
O’Neal, L.W.: Pathologic anatomy in Cushing’s syndrome. Annals of Surgery 160: 860 (1964).
Oswald, I. and Thacore, V.R.: Amphetamine and phenmetrazine addiction. British Medical Journal 2: 1093 (1963).
Pearson, W.S.: The hidden alcoholics in the general hospital. North Carolina Medical Journal 23: 6 (1962).
Platt, R. and Sears, H.T.N.: Reserpine in severe hypertension. Lancet 1: 401 (1956).
Porteous, H.B. and Ross, D.N.: (1956). Mental symptoms in parkinsonism following benzhexol hydrochloride therapy. British Medical Journal 2: 138 (1956).
Prichard, B.N.C.; Johnston, A.W.; Hill, I.D. and Rosenheim, M.L: Bethanidine, guanethidine and methyldopa in treatment of hypertension: a within patient comparison. British Medical Journal 1: 135 (1968).
Quetch, R.M.; Achor, R.W.P.; Litin, E.M. and Faucett, R.L.: Depressive reactions in hypertensive patients. A comparison of those treated with rauwolfia and those receiving no specific antihypertensive treatment. Circulation 19: 366 (1959).
Rose, D.P.: Oral contraceptives and depression. Lancet 2: 321 (1969).
Rosenthal, S.H.: Persistent hallucinosis following administration of hallucinogenic drugs. American Journal of Psychiatry 121: 238 (1964).
Ross, E.J.; Marshall-Jones, P. and Friedman, M.: Cushing’s syndrome in diagnostic criteria. Quarterly Journal of Medicine 35: 149 (1966).
Ruiz, R.C.: D-cycloserine in the treatment of pulmonary tuberculosis resistant to standard drugs. Diseases of the Chest 45: 181 (1964).
Sadove, M.S. and Balagot, R.C.: Double-blind trial of pethidine and pentazocine. Journal of American Medical Association, pp.193 and 887 (1965).
Schildkraut, J.J. and Kety, S.S.: Biogenic amines and emotion. Science 156: 21 (1967).
Scott, D.F.: Alcoholic hallucinosis — an aetiological study. British Journal of Addiction 62: 113 (1967).
Shader, R.I.: Psychiatric effects of non-psychiatric drugs. Seminars in Psychiatry 3: 401 (1971).
Shah, P.M.: Toxic effects of atropine eye drops. Indian Journal of Paediatrics 33: 13 (1966).
Simcoe, C.W.: Cyclopentolate (Cyclogyl) toxicity. Archives of Ophthalmology 67: 406 (1962).
Smith, S.L.: Mood and Menstrual Cycle; in Sachar (Ed.) Topics in Psychoendocrinology, pp. 19–58 (Grune and Stratton, New York, San Francisco and London 1975).
Smith, W.M.; Thurn, R.H. and Bromer, L.: Comparative evaluation of rauwolfia whole root and reserpine. Clinical Pharmacology and Therapeutics 10: 338 (1969).
Stephens, D.A.: Psychotoxic effects of benzhexol hydrochloride. British Journal of Psychiatry 113: 213 (1967).
Tschudy, D.P.: Porphyrin metabolism and the porphyrias; in Bondy (Ed.) Duncan’s Diseases of Metabolism Vol. 1: Genetics and Metabolism, pp. 600–635 (Saunders, Philadelphia 1969).
Ullman, K.C.; Groh, R.H. and Wolff, F.W.: Treatment of scopolamine induced delirium. Lancet 1: 252 (1970).
Ungerleider, J.T.; Fisher, D.D. and Fuller, M.: The dangers of L.S.D. Journal of the American Medical Association 197: 389 (1966).
Victor, M.: Alcoholism. In Barkers Textbook of Neurology Vol. 2, Chapter 22 (Harper and Row, New York 1962).
Victor, M.: Observations on the amnestic syndrome in man and its anatomical basis; in Brazier (Ed.) Brain Function, Vol. 11, RNA and Brain Function, Memory and Learning, pp.36, 40, 687 (University of California Press, Berkley and Los Angeles 1964).
Victor, M.: Treatment of alcoholic intoxication and the withdrawal syndrome; in Seixas (Ed.) Treatment of the Alcoholic Withdrawal Syndrome, pp.41–42; 680–687 (National Council on Alcoholism, New York 1971).
Victor, M. and Hope, J.M.: The phenomenon of auditory hallucinations in chronic alcoholism. Journal of Nervous and Mental Diseases 126: 451 (1958).
Victor, M.; Adams, R.D. and Collins, G.H.: The Wernicke-Korsakoff syndrome (Blackwell Scientific Publications, Oxford 1971).
Walker, W.C. and Murdock, J.M.: Cycloserine in the treatment of pulmonary tuberculosis. Tubercle (London) 38: 297 (1957).
Watson, C.J.: Porphyrin Metabolism; in Duncan (Ed.) Diseases of Metabolism, p.850 (Saunders, Philadelphia, 1964).
Weinstein, H.J.; Hallett, W.Y. and Sarauw, A.S.: The absorption and toxicity of ethionamide. American Review of Respiratory Diseases 86: 576 (1962).
Weatherall, M.: Drugs and porphyrin metabolism. Pharmacology Review 6: 133 (1954).
World Health Organisation: The use of cannabis: report of WHO scientific group. WHO Technical Report No. 478 (WHO, Geneva 1971).
Wolfe, S.M. and Victor, M.: The relationship of hypo-magnesium and alkalosis to alcohol withdrawal symptoms. Annals of New York Academy of Science 162: 973 (1969).
Woodbury, D.M.: Relationship between the adrenal cortex and the central nervous system. Pharmacology Review 10: 275 (1958).
Wynne-Davies, D.: Physical illness in psychiatric out-patients. British Journal of Psychiatry 111: 27 (1965).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Johnson, D.A.W. Drug-induced Psychiatric Disorders. Drugs 22, 57–69 (1981). https://doi.org/10.2165/00003495-198122010-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198122010-00004